跳至主要内容
临床试验/CTRI/2017/10/010089
CTRI/2017/10/010089已完成未知

Safety and efficacy of quick penetrating Heparin solution for prophylaxis against superficial venous cannula- A prospective, randomized, comparative clinical study.

PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Planned to undergo peripheral vein cannulation that has been planned to remain in situ for at least 48 hours of indoor period

排除标准

  • 1.Undergoing re-cannulation due to phlebitis at earlier cannulation site 2.Unconscious or comatose patients
  • 3.History of hypersensitivity reaction to heparin or heparin induced thrombocytopenia
  • 4. Signs of systemic infection, bacteremia
  • 5. Planned administration of any of the following during study period:
  • 5.1 Anti-coagulants locally (in the cannula) or systemically.
  • 5.2 NSAIDs locally over surrounding area
  • 6. Participated in any clinical trial within last 30 days at the time of screening.
  • 7. Any disorder or condition that in the opinion of investigator would prohibit study participation or affect study outcome.

研究者

发起方
PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH

相似试验